Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Georgios L Voulgaris"'
Autor:
Margarita Kyriakidou, Matthew E. Falagas, Anthony R.M. Coates, Georgios L Voulgaris, Panagiota Giakkoupi, Yanmin Hu, Alkiviadis Vatopoulos, Kyriaki Tryfinopoulou
Publikováno v:
International Journal of Antimicrobial Agents. 53:855-858
BACKGROUND: New antibiotics are urgently needed for the treatment of multidrug resistant infections. However, the production of novel antibiotics is diminishing. The enhancement of activity of available antibiotics through synergistic combination dru
Autor:
Nikolaos A. Triarides, Matthew E. Falagas, Florentia Athanasaki, Georgios L Voulgaris, Konstantinos Z. Vardakas
Publikováno v:
International journal of antimicrobial agents. 53(1)
Fosfomycin has been used for the treatment of infections due to susceptible and multidrug-resistant (MDR) bacteria. It inhibits bacterial cell wall synthesis through a unique mechanism of action at a step prior to that inhibited by β-lactams. Fosfom
Autor:
Konstantinos Z. Vardakas, Georgios Papanikolaou, Nicholas J. Legakis, Tilemachos Skalidis, Georgios L Voulgaris, Matthew E. Falagas
Publikováno v:
International journal of antimicrobial agents. 52(2)
TP-6076 is a synthetic fluorocycline antibiotic that inhibits bacterial protein synthesis. In this study, carbapenem-resistant Acinetobacter baumannii clinical isolates from 13 Greek hospitals were tested for susceptibility to TP-6076 and comparator
Publikováno v:
International journal of antimicrobial agents. 51(1)
Background Inhaled colistin is becoming increasingly popular against respiratory tract infections caused by multidrug resistant (MDR) Gram-negative bacteria because it may overcome the problems associated with intravenous (IV) administration. Objecti